Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Onal

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patientsCem Onal, Gokhan Ozyigit, Ozan Cem Guler, et al.
Radiation Medicine and Protection|March 19, 2026
A comparison of dimensionality reduction approaches for pre-treatment PSMA-PET/CT radiomics in prostate adenocarcinoma outcome predictionApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2021
Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational StudyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao Weng Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2025
Gallium-68-Labeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Response in Pelvic Node-Positive Prostate Cancer After Definitive Radiation Therapy: Prognostic ImplicationsCem Onal, Ozan Cem Guler, Nese Torun, et al.
Breast (Edinburgh, Scotland)|August 20, 2018
Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 studyOzlem Ozkaya Akagunduz, Arzu Ergen, Petek Erpolat, et al.
Clinical Nuclear Medicine|March 4, 2021
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 StudyCem Onal, Gokhan Ozyigit, Zuleyha Akgun, et al.
The Journal of Obstetrics and Gynaecology Research|April 6, 2022
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomesSezin Yuce Sari, Ozan Cem Guler, Ezgi Oymak, et al.
Clinical Nuclear Medicine|June 7, 2024
Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy: Comparative Analysis of PSMA PET/CT and Conventional ImagingCem Onal, Ozan Cem Guler, Petek Erpolat, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateBerna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Future Oncology (London, England)|April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateCem Onal, Ali Murat Sedef, Fatih Kose, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patientsCem Onal, Gokhan Ozyigit, Ozan Cem Guler, et al.
Radiation Medicine and Protection|March 19, 2026
A comparison of dimensionality reduction approaches for pre-treatment PSMA-PET/CT radiomics in prostate adenocarcinoma outcome predictionApurva Singh, William Silva Mendes, Sang-Bo Oh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2021
Real-World Treatment Patterns and Clinical Outcomes in Patients With Stage III NSCLC: Results of KINDLE, a Multicountry Observational StudyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao Weng Tan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2025
Gallium-68-Labeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Response in Pelvic Node-Positive Prostate Cancer After Definitive Radiation Therapy: Prognostic ImplicationsCem Onal, Ozan Cem Guler, Nese Torun, et al.
Breast (Edinburgh, Scotland)|August 20, 2018
Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 studyOzlem Ozkaya Akagunduz, Arzu Ergen, Petek Erpolat, et al.
Clinical Nuclear Medicine|March 4, 2021
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 StudyCem Onal, Gokhan Ozyigit, Zuleyha Akgun, et al.
The Journal of Obstetrics and Gynaecology Research|April 6, 2022
Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomesSezin Yuce Sari, Ozan Cem Guler, Ezgi Oymak, et al.
Clinical Nuclear Medicine|June 7, 2024
Evaluation of Treatment Outcomes of Prostate Cancer Patients With Lymph Node Metastasis Treated With Definitive Radiotherapy: Comparative Analysis of PSMA PET/CT and Conventional ImagingCem Onal, Ozan Cem Guler, Petek Erpolat, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateBerna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Future Oncology (London, England)|April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetateCem Onal, Ali Murat Sedef, Fatih Kose, et al.
Pageof 15